Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants
NCT00622505
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
121
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
zoledronic acid
Sponsor
Novartis Pharmaceuticals